Multislice computed tomography perfusion in the diagnosis and differentiation of pancreatic carcinoma
Qianqian Liu,Xiaohua Huang,Guoli Dong,Xiaoming Zhang,Zonglin Jing,Jing Guo,Ke Pan
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.14.011
2014-01-01
Abstract:ObjectiveTo investigate the value of MSCT perfusion diagnosis and differential diagnosis of pancreatic carcinoma.Methods 93 patients were divided into the normal control group (48 cases), the pancreatic carcinoma group (31 cases) and the acute pancreatitis group (14 cases) according to the inclusion criteria. CT perfusion imaging of pancreas was done to each group. All perfusion data were transmitted to post-process workstation, at which the blood flow (BF), blood volume (BV), permeability surface (PS), mean transit time (MTT) were measured by using pancreas perfusion software and calculate PS/BF in each group. All the data were recorded and statistically analyzed.ResultsThe BF, BV, PS, MTT and PS/BF of the normal control group were (120.196±27.686)ml·(100 g)-1·min-1, (25.324± 5.012)ml/100 g, (18.314±22.227)ml·(100 g)-1·min-1, (13.655±2.780)s, 0.150±0.770, respectively. The BF, BV, PS, MTT and PS/BF of the pancreatic carcinoma group were (52.674±19.823)ml·(100 g)-1·min-1, (10.369±5.439)ml/100 g, (42.612±17.040)ml·(100 g)-1·min-1, (13.559±5.514)s, 0.844±0.312, respectively.The BF, BV, PS, MTT and PS/BF of the acute pancreatitis group were (89.689±26.788)ml·(100 g)-1·min-1, (18.221±7.600)ml/100 g, (41.342±21.581)ml·(100 g)-1·min-1, (15.018±6.600)s, 0.498±0.287, respectively. Pancreatic carcinoma BF, BV, PS/BF with normal pancreas and acute pancreatitis were statistically significant (P<0.01). Pancreatic carcinoma and normal pancreatic PS was statistically significant (P<0.05). And acute pancreatitis had no statistically significant (P>0.05). And there was no significant difference among MTT of three groups (P>0.05).Conclusion MSCT perfusion imaging plays an important role in diagnosis of pancreatic carcinoma and BF, PS/BF diagnosis and differential diagnosis of pancreatic carcinoma maximum.